10 Apr Sativex Update


The new regulations concerning Sativex came into force today.

Put simply, Sativex has been moved into schedule 4 of the Misuse of Drugs Regulations so it can now be dealt with by doctors, pharmacists and patients in the same way and with the same restrictions as diazepam (Valium).

If you’ve been following CLEAR’s work on the Sativex scandal you’ll understand that what is really going on here is a corrupt use of ministerial orders falsely to distinguish Sativex from cannabis and protect GW Pharmaceutical’s unlawful monopoly.

Catch up in full by the articles below. The very latest news is that CLEAR is now working with leading counsel to prepare an application for permission to apply for judicial review of the re-scheduling. Watch this space!

Sativex Scandal Demands Judicial Review, 1st April 2013

The Sativex Scandal Deepens. Corruption And Dishonesty At The Home Office, 14th February 2013

Home Office Deception On Medicinal Cannabis, 13th February 2013